Unnamed stage
$23m
Biotech startup using funnel-web spider venom to treat heart attacks raises $23 million
Brisbane biotech Infensa Bioscience raised $23 million to develop a heart-attack and stroke treatment derived from funnel-web spider venom, after spinning out of the University of Queensland.